CY1121564T1 - Σπειρο-ινδολινες για τη θεραπεια και την προφυλαξη απο τη λοιμωξη απο τον αναπνευστικο συγκυτιακο ιο (rsv) - Google Patents

Σπειρο-ινδολινες για τη θεραπεια και την προφυλαξη απο τη λοιμωξη απο τον αναπνευστικο συγκυτιακο ιο (rsv)

Info

Publication number: CY1121564T1
Authority: CY; Cyprus
Prior art keywords: rsv; infection; syntical; indolines; spiro
Prior art date: 2014-10-07

Application number

CY20191100403T

Other languages

Greek (el)

English (en)

Inventor

Stuart Cockerill

Neil Mathews

Simon Ward

Graham Lunn

Michael PARADOWSKI

Jose Miguel Gascon Simorte

Original Assignee

ReViral Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-10-07

Filing date

2019-04-11

Publication date

2020-05-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51946966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1121564(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2019-04-11 Application filed by ReViral Limited filed Critical ReViral Limited

2020-05-29 Publication of CY1121564T1 publication Critical patent/CY1121564T1/el

Links

208000015181 infectious disease Diseases 0.000 title 1
230000002265 prevention Effects 0.000 title 1
230000000241 respiratory effect Effects 0.000 title 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 2
125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 2
125000000171 (C1-C6) haloalkyl group Chemical group 0.000 abstract 1
206010061603 Respiratory syncytial virus infection Diseases 0.000 abstract 1
125000003342 alkenyl group Chemical group 0.000 abstract 1
125000004450 alkenylene group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000002947 alkylene group Chemical group 0.000 abstract 1
125000000304 alkynyl group Chemical group 0.000 abstract 1
125000004429 atom Chemical group 0.000 abstract 1
150000001556 benzimidazoles Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
239000003112 inhibitor Substances 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CY20191100403T 2014-10-07 2019-04-11 Σπειρο-ινδολινες για τη θεραπεια και την προφυλαξη απο τη λοιμωξη απο τον αναπνευστικο συγκυτιακο ιο (rsv) CY1121564T1 (el)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB1417707.5A GB201417707D0 (en)	2014-10-07	2014-10-07	Pharmaceutical compounds
PCT/GB2015/052920 WO2016055780A1 (en)	2014-10-07	2015-10-06	Spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (rsv)

Publications (1)

Publication Number	Publication Date
CY1121564T1 true CY1121564T1 (el)	2020-05-29

Family

ID=51946966

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CY20191100403T CY1121564T1 (el)	2014-10-07	2019-04-11	Σπειρο-ινδολινες για τη θεραπεια και την προφυλαξη απο τη λοιμωξη απο τον αναπνευστικο συγκυτιακο ιο (rsv)

Country Status (31)

Country	Link
US (1)	US10106539B2 (2)
EP (1)	EP3204375B1 (2)
JP (1)	JP6695334B2 (2)
KR (2)	KR20230116097A (2)
CN (1)	CN107108557B (2)
AR (1)	AR102181A1 (2)
AU (1)	AU2015329778B2 (2)
BR (1)	BR112017007311B1 (2)
CA (1)	CA2963740C (2)
CL (1)	CL2017000839A1 (2)
CO (1)	CO2017004603A2 (2)
CY (1)	CY1121564T1 (2)
DK (1)	DK3204375T3 (2)
ES (1)	ES2718976T3 (2)
GB (1)	GB201417707D0 (2)
HR (1)	HRP20190808T1 (2)
HU (1)	HUE043553T2 (2)
LT (1)	LT3204375T (2)
MX (1)	MX373233B (2)
NZ (1)	NZ731323A (2)
PE (1)	PE20170949A1 (2)
PL (1)	PL3204375T3 (2)
PT (1)	PT3204375T (2)
RS (1)	RS58706B1 (2)
RU (1)	RU2734248C2 (2)
SG (1)	SG11201702766YA (2)
SI (1)	SI3204375T1 (2)
SM (1)	SMT201900249T1 (2)
TR (1)	TR201903362T4 (2)
TW (1)	TWI718107B (2)
WO (1)	WO2016055780A1 (2)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2821649T3 (es)	2015-06-08	2021-04-27	Shangdong Danhong Pharmaceutical Co Ltd	Método para preparar derivados de imidazol e intermedios de los mismos y formas cristalinas
ES2878058T3 (es) *	2016-08-04	2021-11-18	Reviral Ltd	Derivados de pirimidina y su uso en el tratamiento y la prevención de una infección por virus respiratorio sincitial
GB201711704D0 (en) *	2017-07-20	2017-09-06	Reviral Ltd	Pharmaceutical compounds
GB201721812D0 (en)	2017-12-22	2018-02-07	Reviral Ltd	Pharmaceutical compounds
CN116077494A (zh) *	2023-01-11	2023-05-09	黑龙江中医药大学	一种治疗呼吸道合胞病毒的药物组合物及其制备方法
WO2024174953A1 (zh) *	2023-02-21	2024-08-29	苏州隆博泰药业有限公司	苯并咪唑类衍生物及其医药用途
WO2024252355A1 (en)	2023-06-08	2024-12-12	Pfizer Inc.	Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv
WO2025120500A1 (en)	2023-12-06	2025-06-12	Pfizer Inc.	Benzodiazepine compounds as n-protein inhibitors
WO2025153942A1 (en)	2024-01-16	2025-07-24	Pfizer Inc.	Benzodiazepine pyrazolo carboxamides as n-protein inhibitors
WO2025248535A1 (en) *	2024-05-29	2025-12-04	Zydus Lifesciences Limited	Novel spirocyclic compounds to treat viral infections

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57102863A (en) *	1980-12-16	1982-06-26	Takeda Chem Ind Ltd	Spiroindolinone and its preparation
PL194216B1 (pl) *	1998-01-23	2007-05-31	Sankyo Co	Pochodne spiropiperydyny, lekarstwo oraz środek zapobiegawczy lub terapeutyczny zawierające jako składnik czynny te pochodne i zastosowanie pochodnych spiropiperydyny
SI1196408T1 (en) *	1999-06-28	2005-02-28	Janssen Pharmaceutica N.V.	Respiratory syncytial virus replication inhibitors
US6774134B2 (en)	2000-12-20	2004-08-10	Bristol-Myers Squibb Company	Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US6919331B2 (en)	2001-12-10	2005-07-19	Bristol-Myers Squibb Company	Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
US7205328B2 (en) *	2002-10-21	2007-04-17	Irm Llc	Oxindoles with anti-HIV activity
JO2355B1 (en)	2003-04-15	2006-12-12	ميرك شارب اند دوم كوربوريشن	Hereditary calcitonin polypeptide receptor antagonists
US7390798B2 (en)	2004-09-13	2008-06-24	Merck & Co., Inc.	Carboxamide spirolactam CGRP receptor antagonists
BRPI0517418A (pt)	2004-10-13	2008-10-07	Merck & Co Inc	composto, composição farmacêutica, e, métodos para antagonismo de atividade do receptor de cgrp em um mamìfero, para tratar, controlar, melhorar ou reduzir o risco de dor de cabeça, enxaqueca ou cefalgia, e de tratamento ou prevenção de dores de cabeça de enxaqueca, cefalgias, e dores de cabeça
US20100278835A1 (en)	2009-03-10	2010-11-04	Astrazeneca Uk Limited	Novel compounds 660
GB201119538D0 (en) *	2011-11-10	2011-12-21	Viral Ltd	Pharmaceutical compounds
MY172021A (en)	2012-10-16	2019-11-12	Janssen Sciences Ireland Uc	Rsv antiviral compounds
EP2997028A1 (en)	2013-05-14	2016-03-23	F.Hoffmann-La Roche Ag	Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
KR20160007629A (ko) *	2013-05-14	2016-01-20	에프. 호프만-라 로슈 아게	호흡기 세포융합 바이러스 감염의 치료 및 예방을 위한 아자-옥소-인돌
CN105392787B (zh) *	2013-05-14	2017-11-24	豪夫迈·罗氏有限公司	用于治疗和预防呼吸道合胞病毒感染的氮杂‑氧代‑吲哚
KR20160030271A (ko) *	2013-08-12	2016-03-16	에프. 호프만-라 로슈 아게	호흡기 세포융합 바이러스 감염의 치료 및 예방을 위한 아자-옥소-인돌
CN105408330A (zh) *	2013-08-12	2016-03-16	豪夫迈·罗氏有限公司	新的用于治疗和预防呼吸道合胞病毒感染的氮杂-氧代-吲哚
JP6211195B2 (ja) *	2013-08-12	2017-10-11	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	呼吸器合胞体ウイルス感染症の処置および予防のための新規アザ−オキソ−インドール
CN105431419A (zh) *	2013-08-15	2016-03-23	豪夫迈·罗氏有限公司	新的用于治疗和预防呼吸道合胞病毒感染的氮杂-氧代-吲哚
HK1222855A1 (zh) *	2013-08-15	2017-07-14	F. Hoffmann-La Roche Ag	新的用於治疗和预防呼吸道合胞病毒感染的氮杂-氧代-吲哚
KR20160030569A (ko) *	2013-08-15	2016-03-18	에프. 호프만-라 로슈 아게	호흡기 세포융합 바이러스 감염의 치료 및 예방을 위한 신규한 아자-옥소-인돌

2014
- 2014-10-07 GB GBGB1417707.5A patent/GB201417707D0/en not_active Ceased
2015
- 2015-10-06 TR TR2019/03362T patent/TR201903362T4/tr unknown
- 2015-10-06 JP JP2017519320A patent/JP6695334B2/ja active Active
- 2015-10-06 CN CN201580066385.4A patent/CN107108557B/zh active Active
- 2015-10-06 KR KR1020237025697A patent/KR20230116097A/ko active Pending
- 2015-10-06 BR BR112017007311-0A patent/BR112017007311B1/pt active IP Right Grant
- 2015-10-06 PE PE2017000576A patent/PE20170949A1/es unknown
- 2015-10-06 CA CA2963740A patent/CA2963740C/en active Active
- 2015-10-06 RU RU2017113026A patent/RU2734248C2/ru active
- 2015-10-06 ES ES15782033T patent/ES2718976T3/es active Active
- 2015-10-06 DK DK15782033.3T patent/DK3204375T3/en active
- 2015-10-06 PT PT15782033T patent/PT3204375T/pt unknown
- 2015-10-06 AR ARP150103215A patent/AR102181A1/es not_active Application Discontinuation
- 2015-10-06 SI SI201530634T patent/SI3204375T1/sl unknown
- 2015-10-06 WO PCT/GB2015/052920 patent/WO2016055780A1/en not_active Ceased
- 2015-10-06 SM SM20190249T patent/SMT201900249T1/it unknown
- 2015-10-06 KR KR1020177012311A patent/KR102561796B1/ko active Active
- 2015-10-06 HU HUE15782033A patent/HUE043553T2/hu unknown
- 2015-10-06 US US15/517,290 patent/US10106539B2/en active Active
- 2015-10-06 NZ NZ731323A patent/NZ731323A/en unknown
- 2015-10-06 EP EP15782033.3A patent/EP3204375B1/en active Active
- 2015-10-06 AU AU2015329778A patent/AU2015329778B2/en active Active
- 2015-10-06 RS RS20190515A patent/RS58706B1/sr unknown
- 2015-10-06 MX MX2017004425A patent/MX373233B/es active IP Right Grant
- 2015-10-06 PL PL15782033T patent/PL3204375T3/pl unknown
- 2015-10-06 HR HRP20190808TT patent/HRP20190808T1/hr unknown
- 2015-10-06 LT LTEP15782033.3T patent/LT3204375T/lt unknown
- 2015-10-06 SG SG11201702766YA patent/SG11201702766YA/en unknown
- 2015-10-07 TW TW104133092A patent/TWI718107B/zh active
2017
- 2017-04-06 CL CL2017000839A patent/CL2017000839A1/es unknown
- 2017-05-05 CO CONC2017/0004603A patent/CO2017004603A2/es unknown
2019
- 2019-04-11 CY CY20191100403T patent/CY1121564T1/el unknown

Also Published As

Publication number	Publication date
HRP20190808T1 (hr)	2019-08-23
RS58706B1 (sr)	2019-06-28
HUE043553T2 (hu)	2019-09-30
SG11201702766YA (en)	2017-05-30
TW201625583A (zh)	2016-07-16
MX373233B (es)	2020-05-08
BR112017007311B1 (pt)	2022-11-22
TWI718107B (zh)	2021-02-11
NZ731323A (en)	2022-09-30
GB201417707D0 (en)	2014-11-19
AU2015329778A1 (en)	2017-05-04
AU2015329778A8 (en)	2017-05-18
CA2963740A1 (en)	2016-04-14
RU2017113026A3 (2)	2019-03-22
PL3204375T3 (pl)	2019-06-28
AR102181A1 (es)	2017-02-08
ES2718976T3 (es)	2019-07-05
PE20170949A1 (es)	2017-07-13
CN107108557A (zh)	2017-08-29
KR102561796B1 (ko)	2023-07-31
PT3204375T (pt)	2019-04-01
AU2015329778B2 (en)	2020-04-23
SMT201900249T1 (it)	2019-07-11
CN107108557B (zh)	2020-11-10
KR20230116097A (ko)	2023-08-03
JP2017530992A (ja)	2017-10-19
CL2017000839A1 (es)	2017-10-13
WO2016055780A1 (en)	2016-04-14
RU2017113026A (ru)	2018-11-13
JP6695334B2 (ja)	2020-05-20
CA2963740C (en)	2022-11-29
US20170305908A1 (en)	2017-10-26
EP3204375A1 (en)	2017-08-16
CO2017004603A2 (es)	2017-10-31
DK3204375T3 (en)	2019-04-01
US10106539B2 (en)	2018-10-23
EP3204375B1 (en)	2019-02-13
RU2734248C2 (ru)	2020-10-13
LT3204375T (lt)	2019-05-10
BR112017007311A2 (pt)	2017-12-19
KR20170066577A (ko)	2017-06-14
TR201903362T4 (tr)	2019-04-22
SI3204375T1 (sl)	2019-05-31
MX2017004425A (es)	2017-10-11

Publication	Publication Date	Title
CY1121564T1 (el)	2020-05-29	Σπειρο-ινδολινες για τη θεραπεια και την προφυλαξη απο τη λοιμωξη απο τον αναπνευστικο συγκυτιακο ιο (rsv)
CY1123994T1 (el)	2022-05-27	Δικυκλικες-συντηγμενες ενωσεις ετεροαρυλιου ή αρυλιου ως ρυθμιστες της irak4
JOP20240216A1 (ar)	2024-09-30	مثبطات kras g12c
CY1125214T1 (el)	2023-06-09	Ενωσεις ν-((ετ)αρυλμεθυλ)-ετεροαρυλ-καρβοξαμιδιων ως αναστολεις καλλικρεϊνης πλασματος
CY1121047T1 (el)	2019-12-11	Ενωσεις αμιδιου για τη θεραπεια toy hiv
CY1117428T1 (el)	2017-04-26	Φαρμακευτικες ενωσεις
HUE072195T2 (hu)	2025-10-28	Terápiás vegyületek HIV-vírusfertõzésre
CY2022039I1 (el)	2023-01-27	Θεραπευτικες ενωσεις χρησιμες για την προφυλακτικη ή θεραπευτικη αγωγη μολυνσης ιου ηiv
CY1121694T1 (el)	2020-07-31	Ενωσεις δι-κυκλικου-συντηγμενου ετεροαρυλιου ή αρυλιου και η χρηση αυτων ως αναστολεις irak4
CY1122340T1 (el)	2021-01-27	Αντιπολλαπλασιαστικες ενωσεις και μεθοδοι χρησης αυτων
CY1124173T1 (el)	2022-05-27	Υποκατεστημενες ενωσεις αμινοπουρινης, συνθεσεις αυτων και μεθοδοι θεραπειας με αυτες
EA202092451A1 (ru)	2021-03-16	Соединения
CY1124537T1 (el)	2022-07-22	Παραγωγο πυριδονης που εχει τετραϋδροπυρανυλ μεθυλ ομαδα
CY1121433T1 (el)	2020-05-29	Παραγωγα δικυκλικων ετεροκυκλυλιων ως αναστολεις irak4
CY1120826T1 (el)	2019-12-11	Τριυποκατεστημενα παραγωγα βενζοτριαζολης ως αναστολεις διϋδροοροτικης οξυγενασης
MX2019001581A (es)	2019-06-20	Inhibidores de ssao de aminopirimidina.
CY1117905T1 (el)	2017-05-17	Αναστολεις πρωτεϊνικης κινασης
AR100251A1 (es)	2016-09-21	Inhibidores de la dematilasa-1 especifica de lisina
CR20120397A (es)	2013-05-15	Inhibidores del virus de la hepatitis c
BR112018002071A2 (pt)	2018-09-18	compostos heteroarílicos ou arílicos fundidos bicíclicos
CY1124058T1 (el)	2022-05-27	Διαδικασια κρυσταλλωσης των παραγωγων αριπιπραζολης σε φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης για τη θεραπευτικη αντιμετωπιση της σχιζοφρενειας
EA201591486A1 (ru)	2016-01-29	Соединения имидазопиридина
CY1124479T1 (el)	2022-07-22	Ενωσεις που περιεχουν υποκατεστημενο αζωτο
JOP20190130A1 (ar)	2019-06-02	مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv)
CY1126466T1 (el)	2026-02-25	Παραγωγα φαινυλιου/πυριδυλ-νη-φαινυλιου/ πυριδυλιου για τη θεραπευτικη αντιμετωπιση ιικωνλοιμωξεων